Journal ID (nlm-ta): PLoS Negl Trop Dis
Journal ID (iso-abbrev): PLoS Negl Trop Dis
Journal ID (publisher-id): plos
Journal ID (pmc): plosntds
Title:
PLoS Neglected Tropical Diseases
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Print):
1935-2727
ISSN
(Electronic):
1935-2735
Publication date
(Electronic):
2
March
2016
Publication date Collection:
March
2016
Volume: 10
Issue: 3
Electronic Location Identifier: e0003895
Affiliations
[1
]Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development,
National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas,
United States of America
[2
]Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland
[3
]Drugs for Neglected Diseases Initiative (DNDi), Delhi, India
[4
]Foundation for Innovative new Diagnostics (FIND), Geneva, Switzerland
[5
]Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New
Haven, Connecticut, United States of America
[6
]National Institute for Medical Research, Dar es Salaam, Tanzania
[7
]Carlos Slim Foundation, Mexico City, Mexico
[8
]UNICEF/UNDP/ World Bank/WHO Special Programme for Research and Training in Tropical
Diseases (TDR), Geneva, Switzerland
New York Blood Center, UNITED STATES
Author notes
We have read the journal's policy and the authors of this manuscript have the following
competing interests: Peter J. Hotez is principal investigator and patent holder on
vaccines against hookworm and schistosomiasis, as well as principal investigator on
several other vaccines in development against Neglected Tropical Diseases.
Article
Publisher ID:
PNTD-D-15-00400
DOI: 10.1371/journal.pntd.0003895
PMC ID: 4774924
PubMed ID: 26934395
SO-VID: 02ef6854-77ce-45f9-a3eb-2c7434776765
Copyright © © 2016 Hotez et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
The Article Processing Charges for this paper were funded by The Bill & Melinda Gates
Foundation, which also provided funding for a commissioning fee of US$2,000. The authors
donated their US$2,000 commissioning fee to the END Fund, which funds mass drug administration
for NTDs (see
www.end.org). The funders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Subject:
Review
Subject:
Medicine and Health Sciences
Subject:
Tropical Diseases
Subject:
Neglected Tropical Diseases
Subject:
Medicine and Health Sciences
Subject:
Infectious Diseases
Subject:
Infectious Disease Control
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Vaccination and Immunization
Subject:
Vaccines
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Vaccination and Immunization
Subject:
Vaccines
Subject:
Medicine and Health Sciences
Subject:
Public and Occupational Health
Subject:
Preventive Medicine
Subject:
Vaccination and Immunization
Subject:
Vaccines
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Vaccination and Immunization
Subject:
Vaccine Development
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Vaccination and Immunization
Subject:
Vaccine Development
Subject:
Medicine and Health Sciences
Subject:
Public and Occupational Health
Subject:
Preventive Medicine
Subject:
Vaccination and Immunization
Subject:
Vaccine Development
Subject:
Medicine and Health Sciences
Subject:
Public and Occupational Health
Subject:
Global Health
Subject:
Medicine and Health Sciences
Subject:
Epidemiology
Subject:
Disease Vectors
Subject:
Insect Vectors
Subject:
Medicine and Health Sciences
Subject:
Parasitic Diseases
Subject:
Helminth Infections
Subject:
Schistosomiasis
Subject:
Medicine and Health Sciences
Subject:
Tropical Diseases
Subject:
Neglected Tropical Diseases
Subject:
Schistosomiasis
Subject:
Medicine and Health Sciences
Subject:
Pharmacology
Subject:
Drug Research and Development
